600216 浙江醫藥
按盤價 
10.930 -0.050 (-0.455%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.132 | 4.549 | 5.982 | 12.706 | 9.240 |
| 總資產報酬率 ROA (%) | 0.854 | 3.408 | 4.323 | 9.077 | 6.877 |
| 投入資產回報率 ROIC (%) | 1.035 | 4.160 | 5.411 | 11.300 | 8.223 | 邊際利潤分析 |
| 銷售毛利率 (%) | 32.917 | 32.387 | 34.470 | 40.851 | 41.539 |
| 營業利潤率 (%) | 4.526 | 4.877 | 6.218 | 12.920 | 12.046 |
| 息稅前利潤/營業總收入 (%) | 4.582 | 4.437 | 5.587 | 13.656 | 12.571 |
| 淨利潤/營業總收入 (%) | 3.529 | 3.551 | 4.468 | 9.689 | 9.003 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 116.562 | 30.963 | 128.977 | 103.750 | 95.252 |
| 價值變動淨收益/利潤總額(%) | -8.376 | -3.745 | -11.500 | 8.109 | 17.653 |
| 營業外收支淨額/利潤總額(%) | -0.746 | -4.646 | -2.692 | -2.246 | -3.720 | 償債能力分析 |
| 流動比率 (X) | 2.376 | 2.260 | 2.294 | 1.995 | 2.660 |
| 速動比率 (X) | 1.615 | 1.449 | 1.485 | 1.376 | 1.891 |
| 資產負債率 (%) | 22.025 | 21.856 | 21.900 | 26.733 | 23.527 |
| 帶息債務/全部投入資本 (%) | 8.134 | 7.443 | 8.284 | 9.517 | -- |
| 股東權益/帶息債務 (%) | 1,119.986 | 1,232.741 | 1,100.412 | 942.674 | 770.747 |
| 股東權益/負債合計 (%) | 342.520 | 344.798 | 340.092 | 262.045 | 310.659 |
| 利息保障倍數 (X) | 51.348 | -19.773 | -11.943 | 13.389 | 13.145 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 54.695 | 58.895 | 60.809 | 51.636 | 0.000 |
| 存貨周轉天數 (天) | 114.065 | 136.804 | 130.911 | 111.783 | 0.000 |
| 備註： | 即時報價更新時間為 01/07/2024 11:48 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
